Hospira targeted in generic Aloxi patent infringement case

25-03-2015

Hospira targeted in generic Aloxi patent infringement case

lucarista / Shutterstock.com

Cancer treatment company Helsinn and pharmaceutical company Roche have sued Hospira for allegedly infringing five patents covering intravenous anti-nausea drug Aloxi (palonosetron hydrochloride).


Helsinn, Roche, Hospira, Aloxi, ANDA

LSIPR